IDV vehicle

36F79721D0150

65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Veterans Affairs
OfficeNAC FEDERAL SUPPLY SCHEDULE (36F797)
NAICS325412 — Pharmaceutical Preparation Manufacturing
PSC6505 — Drugs and Biologicals
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIXED PRICE WITH ECONOMIC PRICE ADJUSTMENT
Obligations$0
Current contract valueNot reported
Potential contract value / ceiling$315.4K
Start dateApr 15, 2021
Current end dateNot available
Potential end dateNot available
Latest award activitySep 3, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 20 of 20 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Sep 3, 2026P00019$0ADMINISTRATIVE: POINT OF CONTACT
Mar 17, 2026P00018$0SHORT TERM EXTENSION
Feb 12, 2026P00017$0PRODUCT DELETIONS
Dec 2, 2025P00016$0PUBLIC LAW 2026
Aug 11, 2025P00015$0ADDRESS CHANGE
Jul 8, 2025P00014$0ADMINISTRATIVE CHANGE - POC
May 9, 2025P00013$0ADMINISTRATIVE CHANGE
Dec 2, 2024P00012$0PUBLIC LAW
Aug 20, 2024P00011$0PRODUCT LIFE CYCLE CHANGE
Jul 25, 2024P00010$0PRODUCT ADDITION
Jul 22, 2024P00009$0ADMIN: PRIME VENDOR PROGRAM
May 16, 2024P00008$0PRODUCT ADDITION
Nov 27, 2023P00007$0PUBLIC LAW 2024
Nov 17, 2023P00006$0LIFE CYCLE CHANGE AT PERMANENT FCP
Aug 21, 2023P00005$0PRODUCT LIFE CYCLE CHANGE AT TEMPORARY FCP
Jul 24, 2023P00004$042-2A PRODUCT ADDITION
Nov 29, 2022P00003$0PUBLIC LAW 2023
Nov 30, 2021P00002$0PUBLIC LAW 2022
Sep 20, 2021P00001$0ADMINISTRATIVE CHANGES
Mar 29, 20210$065 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.